Jounce Therapeutics, Inc. JNCE
1.88 0.00 0.00%
At close · May 3
52-week range unavailable
- Open
- 1.92
- Prev close
- 1.88
- Mkt cap
- 98.95M
- Vol
- 11.60M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.88
- High
- 1.93
- Forward P/E
- -1.83
- Beta
- 0.75
- Short ratio
- 0.48
- Inst. own
- 85.33%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 4, 2023
- 50-d avg
- 1.64
- 200-d avg
- 1.93
- 1y target
- 2.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for JNCE has not been loaded yet. Try again in a moment.
Altman Z-Score
0.64 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -1.1×
P/S 0.7×
P/B 0.3×
P/FCF -1.9×
EV/EBITDA 1.7×
EV/Sales -1.0×
FCF Yield -51.9%
Gross Margin 100.0%
Operating Margin -63.7%
Net Margin -62.1%
ROE -27.8%
ROIC -27.0%
ROA -24.0%
Revenue 204.8%
Operating Income 42.6%
EPS (diluted) 45.6%
Free Cash Flow 64.5%
Current Ratio 8.4×
Quick Ratio 8.4×
Debt / Equity 0.1×
Net Debt / EBITDA 2.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31